Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT)

CUSIP: 097702104

Q4 2024 13F Holders as of 31 Dec 2024

Holder snapshot 6 signals
Share change
-753,463
SEC-reported price per share
$0.54
Number of holders
36
Value change
-$538,723
Number of buys
14
Number of sells
11
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
38,512,859

Security key

097702104

Report period

Q4 2024

Institutions

36

Top holders

10

Ownership snapshot

Top reported holders of BOLT - Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Vivo Capital VIII, LLC
Disclosed value leader
Vivo Capital VIII, LLC
Comparable rows
0/15
Latest evidence
30 Sep 2024
3/4/5 13F Highest disclosed value: $5,435,517 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Vivo Capital VIII, LLC has the largest disclosed position value at $5.44M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Vivo Capital VIII, LLC's linked filing trail.
Disclosed position value Top 5
Vivo Capital VIII, LLC $5.44M
Novo Holdings A/S $3.52M
TANG CAPITAL MANAGEMENT LLC $2.47M
Vivo Capital, LLC $2.28M
Edgar Engleman $1.97M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Vivo Capital VIII, LLC
3/4/5
10%+ Owner
—
mixed-class rows
$5,435,517
5,763,311 shares
mixed-class rows
— 21 Nov 2023
Novo Holdings A/S
3/4/5
10%+ Owner
—
denominator unverified
$3,518,791
3,703,991 shares
— 13 Jul 2022
TANG CAPITAL MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$2,470,677
3,812,773 shares
— 30 Sep 2024
Vivo Capital, LLC
13F
Company
13F
—
denominator unverified
$2,281,797
3,521,291 shares
— 30 Sep 2024
Edgar Engleman
3/4/5
Director
—
mixed-class rows
$1,969,355
2,098,005 shares
mixed-class rows
— 29 Nov 2023
Sofinnova Investments, Inc.
13F
Company
13F
—
denominator unverified
$1,784,875
2,754,437 shares
— 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
36
Shares
18,655,032
Rows available
36
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2025 Across Filers

Q3 2025 holders
1
Q4 2024 holders
36
Holder diff
35
Investor Q3 2025 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2025 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .